Sonoma Pharmaceuticals Inc (SNOA)
0.156
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.159
0.00 (0.00%)
After-Hours: 20:00
Sonoma Pharmaceuticals Total Assets (Quarterly): 14.62M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.62M |
September 30, 2023 | 13.64M |
June 30, 2023 | 15.89M |
March 31, 2023 | 16.23M |
December 31, 2022 | 13.93M |
September 30, 2022 | 14.96M |
June 30, 2022 | 17.16M |
March 31, 2022 | 18.84M |
December 31, 2021 | 19.35M |
September 30, 2021 | 19.83M |
June 30, 2021 | 14.12M |
March 31, 2021 | 14.99M |
December 31, 2020 | 18.23M |
September 30, 2020 | 18.14M |
June 30, 2020 | 18.65M |
March 31, 2020 | 14.56M |
December 31, 2019 | 16.50M |
September 30, 2019 | 16.14M |
June 30, 2019 | 16.92M |
March 31, 2019 | 14.45M |
December 31, 2018 | 17.04M |
September 30, 2018 | 14.35M |
June 30, 2018 | 16.63M |
March 31, 2018 | 19.21M |
December 31, 2017 | 18.36M |
Date | Value |
---|---|
September 30, 2017 | 20.15M |
June 30, 2017 | 22.42M |
March 31, 2017 | 25.46M |
December 31, 2016 | 27.51M |
September 30, 2016 | 9.241M |
June 30, 2016 | 11.32M |
March 31, 2016 | 13.80M |
December 31, 2015 | 12.10M |
September 30, 2015 | 13.58M |
June 30, 2015 | 14.21M |
March 31, 2015 | 15.05M |
December 31, 2014 | 11.83M |
September 30, 2014 | 18.39M |
June 30, 2014 | 19.88M |
March 31, 2014 | 20.79M |
December 31, 2013 | 9.843M |
September 30, 2013 | 8.882M |
June 30, 2013 | 10.58M |
March 31, 2013 | 12.56M |
December 31, 2012 | 11.83M |
September 30, 2012 | 13.39M |
June 30, 2012 | 9.693M |
March 31, 2012 | 7.838M |
December 31, 2011 | 8.981M |
September 30, 2011 | 7.763M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.64M
Minimum
Sep 2023
19.83M
Maximum
Sep 2021
16.46M
Average
16.23M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 9.034M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 55.22M |
Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 7.926M |
Shareholders Equity (Quarterly) | 6.692M |
Debt to Equity Ratio | 0.0066 |
Current Ratio | 4.067 |
Net Debt Paydown Yield | 1.62% |